Stay updated on Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added Moscow, Russia (postal code 121205) as a study location and inserted new dates 2026-07-30, 2026-08-20, and 2028-02-16; Removed Krasnogorsk, Russia (postal code 143423) and earlier dates 2026-07-02, 2026-07-06, and 2027-11-30.
    Difference
    0.2%
    Check dated 2026-08-22T16:10:14.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.5, indicating a new revision of the study record. This appears to be an internal maintenance update rather than a change to the study details or how the page functions.
    Difference
    15%
    Check dated 2026-08-08T09:53:33.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Footer revision label updated to Revision: v3.6.4, signaling a minor version update to the site's template without altering content.
    Difference
    0.0%
    Check dated 2026-07-25T01:02:32.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Three new date values (2026-07-06, 2026-07-02, 2026-07) were added to the page, representing recent update timestamps in the study record.
    Difference
    0.1%
    Check dated 2026-07-10T17:14:11.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    A new page revision label v3.6.3 was added and the previous v3.6.2 label was removed, indicating a newer revision of the page metadata.
    Difference
    0.0%
    Check dated 2026-07-03T13:37:05.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.6.2 replaces the previous Revision: v3.6.0 on the page. This update reflects a change to the study record's documentation rather than the study content.
    Difference
    0.0%
    Check dated 2026-06-26T11:47:19.000Z thumbnail image

Stay in the know with updates to Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page.